華錄百納(300291.SZ)::一季度淨利預增75%-105%
格隆匯4月9日丨華錄百納(300291.SZ)披露2020年第一季度業績預告,預計歸屬於上市公司股東的淨利潤1707.99萬元–2000.79萬元,同比增長75%至105%。業績變動原因如下:
1、報告期內公司收入主要來自於媒介資源的硬廣項目投放及過往劇目的多輪發行。雖然項目拍攝目前已陸續復工,但新冠肺炎疫情仍對全年度經營項目規劃有一定影響。
2、公司2020年第一季度非經常性損益對淨利潤的影響金額預計為3600-3800萬元,主要系以攤餘成本計量的金融資產終止確認收益及購買理財產品取得的投資收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.